Related Experiment Video
Updated: Mar 27, 2026
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
The Burden of Rehospitalization for Patients With Liver Cirrhosis
1a Liver Research Institute, Department of Medicine , University of Arizona , Tucson , AZ , USA.
Insights
Advanced liver disease, including cirrhosis, is rising. Identifying high-risk patients for readmission is key to improving care and reducing hospitalizations for liver disease complications.
Area of Science:
- Hepatology
- Healthcare Management
- Public Health
Background:
- Advanced liver disease prevalence is increasing in the US, driven by nonalcoholic fatty liver disease and aging hepatitis C populations.
- Cirrhosis complications are a significant cause of hospital admissions and readmissions.
- Effective strategies are needed to prevent rehospitalization in high-risk cirrhosis patients.
Purpose of the Study:
- To identify key drivers of hospital readmissions and healthcare utilization in patients with advanced liver disease.
- To explore the applicability of heart failure management paradigms to cirrhosis patient care.
- To inform the development of quality measures for cirrhosis readmissions.
Main Methods:
- Review of current literature on advanced liver disease, cirrhosis complications, and hospital readmissions.
- Analysis of patient risk factors for readmission, including MELD scores, hepatic encephalopathy, and comorbidities.
- Examination of healthcare utilization and management strategies in similar chronic conditions like heart failure.
Main Results:
- High Model for End-Stage Liver Disease (MELD) scores, risk of fluid/electrolyte abnormalities, hepatic encephalopathy recurrence, and comorbidities like diabetes are key risk factors for cirrhosis readmission.
- The heart failure management paradigm offers potential insights for optimizing cirrhosis care and reducing readmissions.
- Understanding these drivers is crucial for improving performance on upcoming quality measures.
Conclusions:
- Targeted interventions for high-risk cirrhosis patients are essential to reduce hospital readmissions.
- Adopting strategies from heart failure management may enhance care for advanced liver disease patients.
- Proactive management and understanding of readmission drivers will be critical as new quality measures are implemented.
Abstract:
Advanced liver disease is becoming more prevalent in the United States. This increase has been attributed largely to the growing epidemic of nonalcoholic fatty liver disease and an aging population infected with hepatitis C. Complications of cirrhosis are a major cause of hospital admissions and readmissions. It is important to target efforts for preventing rehospitalization toward patients with cirrhosis who are at the highest risk for readmission, such as those who have high Model for End-Stage Liver Disease scores, are at risk for fluid/electrolyte abnormalities or overt hepatic encephalopathy recurrence, and those who have comorbid conditions (e.g. diabetes). The heart failure management paradigm may provide valuable insights for managing patients with cirrhosis, given the extensive research on preventing hospital readmission and improving health care utilization in this subpopulation. As quality measures related to hospital readmissions for cirrhosis and its complications are adopted by the Centers for Medicare & Medicaid Services and private payers in the future, understanding drivers of hospital readmissions and health care utilization in this vulnerable population are key to improving quality measure performance.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
01:22Heart Failure VI: Adjunct Therapies